Deprescribing & Medication Tapering

What Deprescribing Is

Deprescribing refers to the careful, medically managed reduction or discontinuation of medications - especially psychiatric drugs, sedatives, and pain medications - that are no longer serving their intended purpose, or whose risks and side effects have come to outweigh their benefits.

This is more common than many people realize. A significant number have been on the same drugs for years, sometimes decades, without any serious reassessment of whether the original indication still applies. Others have accumulated multiple prescriptions over time, prescribed at different moments for different reasons, whose combined effects have never been fully evaluated. Still others simply want to be taking less and do not know how to do that safely.

Why It Requires Careful Management

Discontinuing psychiatric medications - antidepressants, antipsychotics, mood stabilizers, sedatives - is not as straightforward as stopping most other drugs. Many of them cause physiological dependence even when taken as prescribed. People are often maintained on them long after they have stopped producing obvious clinical benefit.

Antidepressants - particularly shorter-acting SSRIs and SNRIs - produce discontinuation syndromes that can include dizziness, sensory disturbances, anxiety, and flu-like symptoms, and that are frequently more severe than patients are prepared for. Antipsychotics, on abrupt discontinuation, can produce significant psychiatric destabilization that is easily mistaken for the return of the underlying problem. Mood stabilizers - notably anticonvulsants used for psychiatric purposes - carry rebound seizure risk when stopped too quickly. Benzodiazepines can cause seizures on sudden withdrawal; opioids can produce severe physiological and psychological destabilization. In each case, the appropriate approach is a gradual taper managed in close clinical collaboration.

The most significant issue in practice across all of these is misattribution: withdrawal symptoms are consistently interpreted as relapse or recurrence of the original condition - an interpretation that is sometimes correct, but frequently is not. Distinguishing between the two depends on close clinical attention both to what withdrawal from each drug class actually looks like and to the individual history of the person taking it.

How I Approach It

I approach deprescribing as a clinical process requiring time, attention, and ongoing reassessment - not a protocol to be applied uniformly. The rate of taper, the sequencing when multiple medications are involved, and the management of any symptoms that arise along the way are decisions that need to be made in the context of an individual's history, current condition, and the pharmacology of the specific drug.

Alongside the taper, the underlying difficulties they were addressing need to be understood and, where possible, addressed through means other than medication. Deprescribing is most helpful and lasting when the conditions that made them necessary in the first place are being addressed - not only the drugs themselves.

Frequently Asked Questions

Q: What do you mean when you say deprescribing/medication tapering?

A: An incremental reduction in dosage, carried out based on the individual's clinical situation and not on a predetermined timetable. The goal is to allow the nervous system to progressively readjust, rather than face the abrupt removal of a drug it has organized itself around.

Q: How do I know if what I'm feeling is withdrawal or my original condition coming back?

A: Withdrawal symptoms are often difficult to distinguish from the return of the original condition - and the distinction matters considerably. Getting it right calls for careful attention to both the pharmacology of the specific drug and the individual history of the person taking it.

Q: Do psychiatric medications actually work long-term?

A: Long-term efficacy studies for psychiatric drugs - across all classes - are essentially absent from the medical literature. Psychiatric medications can be helpful as part of a broader treatment, particularly in creating conditions that make therapeutic work more accessible. But the evidence does not support medication as a primary or standalone treatment for most psychiatric conditions.

Q: I have been on the same medications for years without reassessment. Is that common?

A: Very common. This is one of the most frequent situations I see.

Getting in Touch

The first conversation is free and completely confidential. There is no obligation of any kind.

Call directly: (646) 418-7077